Rabbit polyclonal Antibody to Bevacizumab/Avastin
Bevacizumab (Avastin) is a humanized polyclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with colon cancer, lung cancer, glioblastoma, renal-cell carcinoma, and age-related macular degeneration. As angiogenesis inhibitor, Bevacizumab blocks angiogenesis by inhibiting vascular endothelial growth factor A (VEGF-A) . Anti-Bevacizumab Antibody, pAb, Rabbit is produced from sera of a rabbit immunized with Bevacizumab.
Product Specifications
Host
Rabbit
Immunogen
Bevacizumab
Clonality
Polyclonal
Applications
ELISA
Purification
Antigen affinity chromatography
Format
Purified
Components
0.5 mg/mL, lyophilized with PBS, pH 7.4, containing 0.02% sodium azide.
Storage Conditions
The antibody is stable in lyophilized form if stored at -20°C or below. The reconstituted antibody can be stored for 2-3 weeks at 2-8°C. For long term storage, aliquot and store at -20°C or below. Avoid repeated freezing and thawing cycles.
Applications Notes
ELISA detection: 0.05-0.2 ‚μg/mL
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470352-100 1x 100 µL
CD31 / PECAM-1 (158-2B3), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742713-100 1x 100 µL
Carboxypeptidase A1 / CPA1 (Pancreatic Cancer Marker) (CPA1/2713), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471237-500 1x 500 µL
P27 / KIP1 (DCS-72.F6 + KIP1/769 (SX53G8) ), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details